Colorectal Cancer Video Perspectives

In this video playlist, Smitha Krishnamurthi, MD, gastrointestinal medical oncologist at Cleveland Clinic, talked about:

• PARADIGM and OPTICAL study results, data on anti-PD-1 antibodies and other highlights from ASCO 2022;
• how anti-EGFR antibody use in the first line for patients with certain types of metastatic colorectal cancer has led to a “change in practice” for many oncologists;
• “what’s most exciting in the targeted therapy space”: MOUNTAINEER data from ASCO GI 2022;
• how “as physicians, we have to get the word out” that young-onset CRC “is rising alarmingly,” spurring many medical organizations to recommend screening begin at age 45; and
• the need for “more thoughtful eligibility criteria” and to focus on patient navigation to improve racial and ethnic disparities in CRC clinical trial enrollment.